Fantinel E - Search Results

1

Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer.

Modena A, Iacovelli R, Scarpa A, Brunelli M, Ciccarese C, Fantinel E, Bimbatti D, Massari F, Martignoni G, Tortora G. Modena A, et al. Among authors: fantinel e. Target Oncol. 2016 Oct;11(5):569-577. doi: 10.1007/s11523-016-0450-9. Target Oncol. 2016. PMID: 27402433 Review.

2

Metastatic castration-resistant prostate cancer: targeting the mechanisms of resistance to abiraterone acetate and enzalutamide.

Modena A, Ciccarese C, Fantinel E, Bimbatti D, Tortora G, Massari F. Modena A, et al. Among authors: fantinel e. Expert Rev Anticancer Ther. 2015;15(9):1037-48. doi: 10.1586/14737140.2015.1063423. Epub 2015 Jul 1. Expert Rev Anticancer Ther. 2015. PMID: 26134919 Review.

3

De novo metastatic castration sensitive prostate cancer: State of art and future perspectives.

Mosillo C, Iacovelli R, Ciccarese C, Fantinel E, Bimbatti D, Brunelli M, Bisogno I, Kinspergher S, Buttigliero C, Tucci M, Caffo O, Tortora G. Mosillo C, et al. Among authors: fantinel e. Cancer Treat Rev. 2018 Nov;70:67-74. doi: 10.1016/j.ctrv.2018.08.005. Epub 2018 Aug 11. Cancer Treat Rev. 2018. PMID: 30121492 Review.

4

Comparison Between Prognostic Classifications in De Novo Metastatic Hormone Sensitive Prostate Cancer.

Iacovelli R, Ciccarese C, Mosillo C, Bimbatti D, Fantinel E, Stefani L, Simbolo M, Romano M, Mazzarotto R, Brunelli M, Bria E, Scarpa A, Lawlor RT, Artibani W, Tortora G. Iacovelli R, et al. Among authors: fantinel e. Target Oncol. 2018 Oct;13(5):649-655. doi: 10.1007/s11523-018-0588-8. Target Oncol. 2018. PMID: 30167971

5

PD-L1 Expression in De Novo Metastatic Castration-sensitive Prostate Cancer.

Iacovelli R, Ciccarese C, Brunelli M, Bogina G, Munari E, Bimbatti D, Mosillo C, Fantinel E, Bria E, Martignoni G, Tortora G. Iacovelli R, et al. Among authors: fantinel e. J Immunother. 2019 Sep;42(7):269-273. doi: 10.1097/CJI.0000000000000287. J Immunother. 2019. PMID: 31261165

6

Complete remission with sunitinib in a poor-risk patient with metastatic renal cell carcinoma: the fine balance between toxicity and efficacy.

Massari F, Ciccarese C, Bimbatti D, Fantinel E, Modena A, Simbolo M, Brunelli M, Artibani W, Martignoni G, Scarpa A, Tortora G. Massari F, et al. Among authors: fantinel e. Anticancer Drugs. 2015 Apr;26(4):469-73. doi: 10.1097/CAD.0000000000000208. Anticancer Drugs. 2015. PMID: 25569703

7

The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies.

Ciccarese C, Iacovelli R, Bria E, Modena A, Massari F, Brunelli M, Fantinel E, Bimbatti D, Zamboni GA, Artibani W, Tortora G. Ciccarese C, et al. Among authors: fantinel e. Immunotherapy. 2017 Jun;9(7):579-587. doi: 10.2217/imt-2017-0018. Immunotherapy. 2017. PMID: 28595514

8

Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies.

Ciccarese C, Iacovelli R, Brunelli M, Massari F, Bimbatti D, Fantinel E, De Marco V, Porcaro AB, Martignoni G, Artibani W, Tortora G. Ciccarese C, et al. Among authors: fantinel e. Eur J Cancer. 2017 Sep;83:237-246. doi: 10.1016/j.ejca.2017.06.030. Epub 2017 Jul 27. Eur J Cancer. 2017. PMID: 28756136 Review.

9

The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer.

Iacovelli R, Ciccarese C, Bria E, Romano M, Fantinel E, Bimbatti D, Muraglia A, Porcaro AB, Siracusano S, Brunelli M, Mazzarotto R, Artibani W, Tortora G. Iacovelli R, et al. Among authors: fantinel e. Clin Genitourin Cancer. 2018 Jun;16(3):e645-e653. doi: 10.1016/j.clgc.2017.12.007. Epub 2017 Dec 27. Clin Genitourin Cancer. 2018. PMID: 29339044

10

Immunotherapy versus standard of care in metastatic renal cell carcinoma. A systematic review and meta-analysis.

Iacovelli R, Ciccarese C, Bria E, Bimbatti D, Fantinel E, Mosillo C, Bisogno I, Brunelli M, Tortora G, Porta C. Iacovelli R, et al. Among authors: fantinel e. Cancer Treat Rev. 2018 Nov;70:112-117. doi: 10.1016/j.ctrv.2018.08.007. Epub 2018 Aug 20. Cancer Treat Rev. 2018. PMID: 30145397 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page